stockrowCapstone Therapeutics Corp. (CAPS) vs Cementos Pacasmayo S.A.A. (CPAC)
- Capstone Therapeutics Corp. CAPS 1.90 −8.21%
- Cementos Pacasmayo S.A.A. CPAC 12.74 +0.08%
Capstone Therapeutics Corp. and Cementos Pacasmayo S.A.A. are both Building Materials companies. Cementos Pacasmayo S.A.A. is the larger, with a market value of $1.1B against $1.8M — 617.1× the size. Capstone Therapeutics Corp. has negative trailing earnings, so its P/E is not meaningful; Cementos Pacasmayo S.A.A. trades at 14.2×. Capstone Therapeutics Corp. grew revenue faster over the last twelve months: 38.9% against 20.7%. Cementos Pacasmayo S.A.A. has the higher net margin (11.4% vs −36.7%) and the higher return on invested capital (13.2% vs −17.2%). Across the 18 metrics below, Cementos Pacasmayo S.A.A. leads on 12 and Capstone Therapeutics Corp. on 6.
Valuation
Profitability
| Metric | CAPS | CPAC | Building Materials median |
|---|---|---|---|
| Gross margin | 25.40% | 41.62% | 26.23% |
| Operating margin | (17.20%) | 21.91% | 14.50% |
| Net margin | (36.68%) | 11.38% | 9.60% |
| Free cash flow margin | (6.33%) | 19.83% | 7.85% |
| Return on equity | (114.39%) | 18.92% | 8.83% |
| Return on assets | (41.47%) | 8.13% | 5.93% |
| Return on invested capital | (17.20%) | 13.18% | 6.51% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack